iScience (Apr 2024)

Dual specificity kinase DYRK3 regulates cell migration by influencing the stability of protrusions

  • Martina Ramella,
  • Lucrezia Maria Ribolla,
  • Sara Surini,
  • Kristyna Sala,
  • Diletta Tonoli,
  • Jean-Michel Cioni,
  • Arpan Kumar Rai,
  • Lucas Pelkmans,
  • Ivan de Curtis

Journal volume & issue
Vol. 27, no. 4
p. 109440

Abstract

Read online

Summary: Plasma membrane-associated platforms (PMAPs) form at specific sites of plasma membrane by scaffolds including ERC1 and Liprin-α1. We identify a mechanism regulating PMAPs assembly, with consequences on motility/invasion. Silencing Ser/Thr kinase DYRK3 in invasive breast cancer cells inhibits their motility and invasive capacity. Similar effects on motility were observed by increasing DYRK3 levels, while kinase-dead DYRK3 had limited effects. DYRK3 overexpression inhibits PMAPs formation and has negative effects on stability of lamellipodia and adhesions in migrating cells. Liprin-α1 depletion results in unstable lamellipodia and impaired cell motility. DYRK3 causes increased Liprin-α1 phosphorylation. Increasing levels of Liprin-α1 rescue the inhibitory effects of DYRK3 on cell spreading, suggesting that an equilibrium between Liprin-α1 and DYRK3 levels is required for lamellipodia stability and tumor cell motility. Our results show that DYRK3 is relevant to tumor cell motility, and identify a PMAP target of the kinase, highlighting a new mechanism regulating cell edge dynamics.

Keywords